These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 25411434)
1. Adjuvant treatment for post-operative head and neck squamous cell carcinoma. Kiyota N; Tahara M; Fujii M Jpn J Clin Oncol; 2015 Jan; 45(1):2-6. PubMed ID: 25411434 [TBL] [Abstract][Full Text] [Related]
2. Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck. Tanvetyanon T; Padhya T; McCaffrey J; Kish JA; Deconti RC; Trotti A; Rao NG Head Neck; 2015 Jun; 37(6):840-5. PubMed ID: 24623654 [TBL] [Abstract][Full Text] [Related]
3. Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative Radiotherapy. Noble AR; Greskovich JF; Han J; Reddy CA; Nwizu TI; Khan MF; Scharpf J; Adelstein DJ; Burkey BB; Koyfman SA Anticancer Res; 2016 Feb; 36(2):785-92. PubMed ID: 26851040 [TBL] [Abstract][Full Text] [Related]
4. Phase II feasibility trial of adjuvant chemoradiotherapy with 3-weekly cisplatin for Japanese patients with post-operative high-risk squamous cell carcinoma of the head and neck. Kiyota N; Tahara M; Okano S; Kawashima M; Matsuura K; Onozawa Y; Nibu K; Hayashi R; Yoshimura K; Ohtsu A Jpn J Clin Oncol; 2012 Oct; 42(10):927-33. PubMed ID: 22923484 [TBL] [Abstract][Full Text] [Related]
5. The importance of margins in head and neck cancer. Baddour HM; Magliocca KR; Chen AY J Surg Oncol; 2016 Mar; 113(3):248-55. PubMed ID: 26960076 [TBL] [Abstract][Full Text] [Related]
6. N2 disease in patients with head and neck squamous cell cancer treated with chemoradiotherapy: is there a role for posttreatment neck dissection? Cho AH; Shah S; Ampil F; Bhartur S; Nathan CO Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1112-8. PubMed ID: 19917924 [TBL] [Abstract][Full Text] [Related]
7. Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: a systematic review with meta-analysis. Winquist E; Oliver T; Gilbert R Head Neck; 2007 Jan; 29(1):38-46. PubMed ID: 17103410 [TBL] [Abstract][Full Text] [Related]
8. Expanding role of the medical oncologist in the management of head and neck cancer. Choong N; Vokes E CA Cancer J Clin; 2008; 58(1):32-53. PubMed ID: 18096865 [TBL] [Abstract][Full Text] [Related]
9. [Planned neck dissection in the treatment of locally advanced head and neck squamous cell carcinoma]. Jiang L; Lou JL; Wang KJ; Fang MY; Fu ZF Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):92-96. PubMed ID: 29429177 [No Abstract] [Full Text] [Related]
10. Target delineation for postoperative treatment of head and neck cancer. Evans M; Beasley M Oral Oncol; 2018 Nov; 86():288-295. PubMed ID: 30409314 [TBL] [Abstract][Full Text] [Related]
11. Paclitaxel, carboplatin, and concomitant radiotherapy for resected patients with high risk head and neck cancer. Agulnik M; Rhee EN; Yao M; Mundt AJ; Feldman LE J Chemother; 2005 Apr; 17(2):237-41. PubMed ID: 15920912 [TBL] [Abstract][Full Text] [Related]
12. Current status and future perspective of postoperative treatment for locally advanced squamous cell carcinoma of the head and neck. Kiyota N; Tahara M; Homma A Jpn J Clin Oncol; 2024 Jun; 54(6):613-619. PubMed ID: 38452121 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin. Hamauchi S; Yokota T; Onozawa Y; Ogawa H; Onoe T; Kamijo T; Iida Y; Nishimura T; Onitsuka T; Yasui H Jpn J Clin Oncol; 2015 Dec; 45(12):1116-21. PubMed ID: 26423341 [TBL] [Abstract][Full Text] [Related]
14. Postoperative strategies after primary surgery for squamous cell carcinoma of the head and neck. Langendijk JA; Ferlito A; Takes RP; Rodrigo JP; Suárez C; Strojan P; Haigentz M; Rinaldo A Oral Oncol; 2010 Aug; 46(8):577-85. PubMed ID: 20400361 [TBL] [Abstract][Full Text] [Related]
15. The Evolving and Future Role of Taxanes in Squamous Cell Carcinomas of the Head and Neck: A Review. Mody MD; Gill HS; Saba NF JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):898-905. PubMed ID: 27389786 [TBL] [Abstract][Full Text] [Related]
16. High-Risk Cutaneous Squamous Cell Cancer of the Head and Neck: Risk Factors for Recurrence and Impact of Adjuvant Treatment. Trosman SJ; Zhu A; Nicolli EA; Leibowitz JM; Sargi ZB Laryngoscope; 2021 Jan; 131(1):E136-E143. PubMed ID: 32065413 [TBL] [Abstract][Full Text] [Related]
17. Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinoma. Cannady SB; Lee WT; Scharpf J; Lorenz RR; Wood BG; Strome M; Lavertu P; Esclamado RM; Saxton JP; Adelstein DJ Head Neck; 2010 Mar; 32(3):348-56. PubMed ID: 19672875 [TBL] [Abstract][Full Text] [Related]
18. Postoperative and postradiation head and neck: role of magnetic resonance imaging. Moore AG; Srinivasan A Top Magn Reson Imaging; 2015 Feb; 24(1):3-13. PubMed ID: 25654417 [TBL] [Abstract][Full Text] [Related]
19. Phase III randomized trial of preoperative concurrent chemoradiotherapy versus preoperative radiotherapy for patients with locally advanced head and neck squamous cell carcinoma. Yi J; Huang X; Xu Z; Liu S; Wang X; He X; Luo D; Luo J; Xiao J; Zhang S; Wang K; Qu Y; Tang Y; Liu W; Xu G; Gao L; Wang D Oncotarget; 2017 Jul; 8(27):44842-44850. PubMed ID: 28179586 [TBL] [Abstract][Full Text] [Related]
20. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer". Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]